Your browser doesn't support javascript.
loading
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.
Syed, Abdullah M; Ciling, Alison; Taha, Taha Y; Chen, Irene P; Khalid, Mir M; Sreekumar, Bharath; Chen, Pei-Yi; Kumar, G Renuka; Suryawanshi, Rahul; Silva, Ines; Milbes, Bilal; Kojima, Noah; Hess, Victoria; Shacreaw, Maria; Lopez, Lauren; Brobeck, Matthew; Turner, Fred; Spraggon, Lee; Tabata, Takako; Ott, Melanie; Doudna, Jennifer A.
Afiliação
  • Syed AM; Gladstone Institutes, San Francisco, CA 94158.
  • Ciling A; Innovative Genomics Institute, University of California, Berkeley, CA 94720.
  • Taha TY; Gladstone Institutes, San Francisco, CA 94158.
  • Chen IP; Innovative Genomics Institute, University of California, Berkeley, CA 94720.
  • Khalid MM; Gladstone Institutes, San Francisco, CA 94158.
  • Sreekumar B; Gladstone Institutes, San Francisco, CA 94158.
  • Chen PY; Department of Medicine, University of California, San Francisco, CA 94143.
  • Kumar GR; Gladstone Institutes, San Francisco, CA 94158.
  • Suryawanshi R; Gladstone Institutes, San Francisco, CA 94158.
  • Silva I; Gladstone Institutes, San Francisco, CA 94158.
  • Milbes B; School of Medicine, Vanderbilt University, Nashville, TN 37232.
  • Kojima N; Gladstone Institutes, San Francisco, CA 94158.
  • Hess V; Gladstone Institutes, San Francisco, CA 94158.
  • Shacreaw M; Curative Inc., San Dimas, CA, 91773.
  • Lopez L; Curative Inc., San Dimas, CA, 91773.
  • Brobeck M; Department of Medicine, University of California, Los Angeles, CA 90095.
  • Turner F; Curative Inc., San Dimas, CA, 91773.
  • Spraggon L; Curative Inc., San Dimas, CA, 91773.
  • Tabata T; Curative Inc., San Dimas, CA, 91773.
  • Ott M; Curative Inc., San Dimas, CA, 91773.
  • Doudna JA; Curative Inc., San Dimas, CA, 91773.
Proc Natl Acad Sci U S A ; 119(31): e2200592119, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35858386

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article